ArticleScientific reports2026
A multi-label cascade flexible neural forest model for predicting the subcellular location of multi-site bacterial proteins.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Predicting the subcellular localization of multi-site bacterial proteins remains challenging because label correlations, limited sample size, and low sequence similarity reduce the effectiveness of conventional multi-label classifiers. In this study, we propose a multi-label cascade flexible neural forest (MLCFN Forest) that combines label-powerset-style coding-classification-decoding with a cascade ensemble of flexible neural tree (FNT) groups. The framework preserves label dependencies, decomposes the induced multi-class task into coordinated binary FNT outputs, and progressively reallocates model capacity to low-confidence samples through confidence-guided sample propagation and feature enhancement across layers. We explicitly note that the cascade FNT backbone builds on our previous CFNForest studies for cancer subtype classification, whereas the present work adapts that backbone to multi-label bacterial protein localization by introducing label-set encoding/decoding, multiclass FNT grouping, and a multi-site protein subcellular localization evaluation workflow. Using Gram-negative and Gram-positive benchmark datasets together with AECA-PSSM and PSSM-DWT features, MLCFN Forest consistently outperformed ML-RBF, ML-KNN, ML-LOC, INSDIF, and MLASSO under jackknife evaluation. For example, it achieved OLA/OAA values of 78.3%/76.4% on the Gram-negative AECA-PSSM dataset, 80.7%/78.5% on the Gram-negative PSSM-DWT dataset, and 80.2%/77.6% on the Gram-positive AECA-PSSM dataset. PCA-based low-dimensional experiments further suggested that the model retained good predictive ability after substantial dimensionality reduction. The present study is limited to classical benchmark datasets and does not yet include an independent external test set, strict nested model selection, or direct benchmarking against protein language model predictors; these points are therefore discussed as limitations and future directions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.